
Personalised treatments designed to fight cancer while minimising side effects.
Prostate cancer begins in the prostate gland, a small organ located below the bladder in men that produces seminal fluid. It is one of the most common cancers among men worldwide. Prostate cancer often grows slowly and may not cause symptoms in the early stages, but some types can be aggressive and spread rapidly without timely treatment.


According to GLOBOCAN 2020, prostate cancer is among the top 5 most common cancers in Malaysian men, with over 3,000 new cases diagnosed annually. The risk increases with age, particularly in men over 50. As Malaysia’s population ages, prostate cancer is expected to become an even more significant health concern.
In its early stages, prostate cancer may not show noticeable symptoms. When symptoms do appear, they can include:
These symptoms can also be caused by non-cancerous conditions such as benign prostatic hyperplasia (BPH), but it is important to consult a doctor if they persist.
Doctors may recommend several tests if prostate cancer is suspected:


The exact cause of prostate cancer is not known, but several risk factors increase the likelihood of developing it:
Most prostate cancers are adenocarcinomas, which develop from the glandular cells. Less common types include small cell carcinomas, neuroendocrine tumours, and transitional cell carcinomas.


Prostate cancer is staged based on how far it has spread:
Confined to a small part of the prostate
Still within the prostate but may be larger or involve both lobes
Spread beyond the prostate to nearby tissues such as seminal vesicles
Spread to lymph nodes, bones, or other organs
Treatment depends on the stage, overall health, and patient preferences. Options include:
Advances in treatment allow many men to live long lives after prostate cancer diagnosis.
At OncoCare Malaysia, our multidisciplinary team includes oncologists specialising in prostate and urological cancers, urologists with expertise in minimally invasive surgery, radiation oncologists, radiologists, pathologists, and oncology nurses. Together, they provide a comprehensive and personalised treatment plan for every patient.